$ASEP.c receives European patent for diagnostic solution. Huge news from Asep Medical (CSE: ASEP) today!
The company has announced that it has received an official allowance of its patent claims that serve as the foundation underlying its first-generation sepsis diagnostic technology, Sepset. The patent further supports the development of Asep’s innovative sepsis diagnostic technology in the European marketplace.
In addition to the granting of the patent in the EU, the company plans to validate the patent in Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, and the UK, providing a wide range of markets where the test may be commercialized once it receives regulatory approval.
$ASEP.c shares are up 7% today, continuing on a 21% rebound from all-time lows. Shares are currently highly oversold, so keep an eye out for a big swing!
$ASEP.c is currently trading at $.3 and is presently valued at $16.84 million.
https://ceo.ca/@newswire/asep-medical-inc-announces-allowance-of-european-patent